FARLETUZUMAB ECTERIBULIN

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Protein Created by `admin` on `Tue Apr 01 22:32:32 GMT 2025` Edited by `admin` on `Tue Apr 01 22:32:32 GMT 2025`
Protein Type	MONOCLONAL ANTIBODY CONJUGATE
Protein Sub Type	IGG1
Sequence Origin	HUMANIZED MOUSE
Sequence Type	COMPLETE
Record UNII	UVG3B5TZN3
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

MORAB-202

Preferred Name

English

FARLETUZUMAB ECTERIBULIN

Official Name

English

ERIBULIN/FARLETUZUMAB ANTIBODY DRUG CONJUGATE

Common Name

English

Farletuzumab ecteribulin [WHO-DD]

Common Name

English

IMMUNOGLOBULIN G1, ANTI-(HUMAN FOLATE RECEPTOR .ALPHA.) (HUMAN-MOUSE MONOCLONAL MORAB-003 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL MORAB-003 .KAPPA.-CHAIN, DIMER, REDUCED, THIOETHER WITH N-(3-(2-(2-(3-MERCAPTO-2,5-DIOXO-1-PYRROLIDINYL)ETHOXY)E

Common Name

English

FARLETUZUMAB ECTERIBULIN [USAN]

Common Name

English

farletuzumab ecteribulin [INN]

Common Name

English

Code System Code Type Description

CAS

2407465-18-1

Created by admin on Tue Apr 01 22:32:32 GMT 2025 , Edited by admin on Tue Apr 01 22:32:32 GMT 2025

PRIMARY

INN

11877

Created by admin on Tue Apr 01 22:32:32 GMT 2025 , Edited by admin on Tue Apr 01 22:32:32 GMT 2025

PRIMARY

SMS_ID

300000023254

Created by admin on Tue Apr 01 22:32:32 GMT 2025 , Edited by admin on Tue Apr 01 22:32:32 GMT 2025

PRIMARY

USAN

HI-185

Created by admin on Tue Apr 01 22:32:32 GMT 2025 , Edited by admin on Tue Apr 01 22:32:32 GMT 2025

PRIMARY

NCI_THESAURUS

C173946

Created by admin on Tue Apr 01 22:32:32 GMT 2025 , Edited by admin on Tue Apr 01 22:32:32 GMT 2025

PRIMARY

FDA UNII

UVG3B5TZN3

Created by admin on Tue Apr 01 22:32:32 GMT 2025 , Edited by admin on Tue Apr 01 22:32:32 GMT 2025

PRIMARY

From	To
1_22	1_96
1_146	1_202
1_222	3_217
1_228	2_228
1_231	2_231
1_263	1_323
1_369	1_427
2_22	2_96
2_146	2_202
2_222	4_217
2_263	2_323
2_369	2_427
3_23	3_89
3_137	3_197
4_23	4_89
4_137	4_197

Glycosylation Type

MAMMALIAN

Glycosylation Link Type	Site
N	1_299
N	2_299

Related Record Type Details


					2O09BG0OWA

PARENT -> CONJUGATE

Amount:

Related Record Type Details


					UVG3B5TZN3

FARLETUZUMAB ECTERIBULIN

ACTIVE MOIETY

Amount:

Structural Modifications

Modification Type	Location Site	Location Type	Residue Modified	Extent	Fragment Name	Fragment Approval
AMINO_ACID_SUBSTITUTION	[1_222] [1_228] [1_231] [2_222] [2_228] [2_231] [3_217] [4_217]	SITE_SPECIFIC		Amount:	UNSPECIFIED SUBSTANCE	b8922b0a (not in database)

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT:SEQUENCE(CALCULATED)	CHEMICAL
Molecular Formula	CHEMICAL